PTC Therapeutics Inc. (PTCT) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    PTC Therapeutics Inc.

    NASDAQ: PTCT · Real-Time Price · USD
    57.26
    -0.75 (-1.29%)
    At close: Sep 05, 2025, 3:59 PM
    57.26
    0.00%
    After-hours: Sep 05, 2025, 04:42 PM EDT

    PTC Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 806.78M 937.82M 698.8M 538.59M
    Cost of Revenue
    		 57.4M 288.12M 44.68M 32.33M
    Gross Profit
    		 749.38M 649.7M 654.12M 506.26M
    Operating Income
    		 -302.57M -349.4M -439.93M -374.94M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -363.12M -696.11M -587.49M -518.34M
    Net Income
    		 -363.3M -626.6M -559.02M -523.9M
    Selling & General & Admin
    		 300.91M 332.54M 326M 285.77M
    Research & Development
    		 534.48M 666.56M 651.5M 540.68M
    Other Expenses
    		 216.56M -353.83M 116.55M 54.75M
    Operating Expenses
    		 1.05B 645.27M 1.09B 881.21M
    Interest Expense
    		 166.99M 129.18M 90.87M 86.02M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 1.11B 1.38B 1.14B 913.54M
    Income Tax Expense
    		 176K -69.51M -28.47M 5.56M
    Shares Outstanding (Basic)
    		 76.85M 74.84M 71.73M 70.47M
    Shares Outstanding (Diluted)
    		 76.85M 74.84M 71.73M 70.47M
    EPS (Basic)
    		 -4.73 -8.37 -7.79 -7.43
    EPS (Diluted)
    		 -4.73 -8.37 -7.79 -7.43
    EBITDA
    		 -120.46M -330.34M -367.78M -368.18M
    EBIT
    		 -196.13M -566.93M -496.62M -432.32M
    Depreciation & Amortization
    		 75.66M 236.59M 128.84M 64.13M

    Add to Watchlist